Require coverage for in vitro fertilization for state employees under the Nebraska State Insurance Program
LB233 would amend the Nebraska State Insurance Program to require coverage for in vitro fertilization (IVF) beginning July 1, while also revising existing statutes on optional group life and group health insurance benefits. The bill preserves the ability of group life and group health contracts to offer certain optional benefits, such as accidental death and dismemberment coverage, dependent coverage, dental coverage, disability coverage, and disability income replacement, but makes clear that these optional coverages are to be offered uniformly to employees and remain employee-paid and elective.
The IVF provisions would require the state insurance program to include coverage for infertility treatment, subject to several limits and conditions. The bill would cap coverage at a lifetime maximum of four completed egg retrievals, limit eligibility to individuals who have been unable to conceive or sustain a successful pregnancy through less expensive and medically viable treatments, and require that covered procedures be performed at facilities meeting standards set by recognized reproductive medicine organizations. It also states that an individual is not denied coverage merely because they forgo a particular treatment if a physician determines it is likely to be unsuccessful.
In practical terms, the bill would expand the benefits available to state employees and their covered dependents under the Nebraska State Insurance Program, shifting some infertility-related costs into the state-sponsored health plan. It would also repeal the original statutory sections being reissued and replace them with updated language, thereby changing the governing insurance statutes for state employee benefit offerings.
The available context suggests the bill was not advanced to enactment, as its last action was indefinite postponement. No committee transcript or recorded votes are provided, so there is no documented floor or committee debate in the supplied materials. Based on the bill text alone, the measure appears to have been a targeted benefit expansion with detailed utilization limits, rather than a broad restructuring of state insurance law.
LB233 would amend Nebraska statutes governing the State Insurance Program to mandate IVF coverage for state employees and to restate provisions on optional group life and group health insurance benefits. It would affect the Nebraska State Insurance Program, state employees, and any covered dependents by requiring infertility coverage with specified limits, while leaving optional supplemental benefits elective and employee-paid. The bill would also repeal and replace the prior statutory sections it reissues, updating the legal framework for these insurance offerings.
The supplied record shows no committee testimony, vote tally, or recorded debate, so there is no direct evidence of support or opposition from the legislative process materials provided. The bill’s text indicates a policy choice favoring expanded fertility benefits for state employees, but its indefinite postponement suggests it did not ultimately gain enough legislative traction to proceed. Overall, the sentiment in the available materials is neutral to unresolved, with no documented public or committee consensus.
The main substantive point of contention likely concerns whether the state should be required to cover IVF for employees and, if so, how broad that coverage should be. The bill addresses cost and scope by limiting coverage to a lifetime maximum of four completed egg retrievals and by restricting eligibility to cases where less expensive, medically viable treatments have failed or are not appropriate. Another likely issue is the requirement that treatment be performed at facilities meeting professional reproductive medicine standards. Because no transcripts are provided, the specific objections or supporters are not identified, but the bill’s detailed limits suggest an effort to balance expanded infertility coverage with cost containment and medical oversight.